These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7866729)

  • 1. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
    Balázs C; Kiss E
    Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
    De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels of adhesion molecules (sICAM-1, sVCAM-1 and sP-selectin) in children and adolescents with thyroid diseases].
    Bossowski A; Urban M; Citko A; Sobotko J; Bossowska A
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2000; 6(2):79-92. PubMed ID: 12818068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin-2 receptor in sera of patients with Graves' disease.
    Balázs C; Farid NR
    Acta Med Hung; 1991; 48(1-2):3-11. PubMed ID: 1813855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy.
    De Bellis A; Di Martino S; Fiordelisi F; Muccitelli VI; Sinisi AA; Abbate GF; Gargano D; Bellastella A; Bizzarro A
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1222-5. PubMed ID: 9543145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
    Wenisch C; Myskiw D; Gessl A; Graninger W
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of possible antiidiotypic control mechanisms in Graves' disease.
    Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
    J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary clinical application of sICAM-1 RIA in three kinds of thyroid disease.
    Lu M; Fang P; Zhang Z; He H; Gao S; Hou B; Zheng R; Xiao Q; Yang L
    Chin Med J (Engl); 2002 Oct; 115(10):1552-5. PubMed ID: 12490109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular adhesion molecule-1 (ICAM-1) in the sera of patients with Graves' disease: correlation with disease activity and treatment status.
    Fukazawa H; Yoshida K; Kaise N; Kiso Y; Sayama N; Mori K; Kikuchi K; Aizawa Y; Rikimaru A; Abe K
    Thyroid; 1995 Oct; 5(5):373-7. PubMed ID: 8563475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.
    Heufelder AE; Bahn RS
    Clin Exp Immunol; 1993 May; 92(2):296-302. PubMed ID: 8097976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I; Horváth S; Balázs C
    Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease.
    Balázs C; Molnár I
    Acta Microbiol Immunol Hung; 1995; 42(2):163-9. PubMed ID: 7551709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy.
    Wakelkamp IM; Gerding MN; van der Meer JW; Prummel MF; Wiersinga WM
    Clin Exp Immunol; 2002 Feb; 127(2):316-20. PubMed ID: 11876756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.